Published in Endocrinology on June 09, 2010
A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes (2011) 1.10
Cholecystokinin and pancreatic cancer: the chicken or the egg? Am J Physiol Gastrointest Liver Physiol (2013) 0.96
Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis. Mol Endocrinol (2015) 0.87
Tcf19 is a novel islet factor necessary for proliferation and survival in the INS-1 β-cell line. Am J Physiol Endocrinol Metab (2013) 0.85
Diminished mTOR signaling: a common mode of action for endocrine longevity factors. Springerplus (2014) 0.84
Potential roles of GPR120 and its agonists in the management of diabetes. Drug Des Devel Ther (2014) 0.84
Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat. Dig Dis Sci (2014) 0.83
Different downstream signalling of CCK1 receptors regulates distinct functions of CCK in pancreatic beta cells. Br J Pharmacol (2015) 0.80
Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice. Pancreas (2014) 0.79
Recent advances in pancreatic endocrine and exocrine secretion. Curr Opin Gastroenterol (2011) 0.78
New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders. World J Diabetes (2015) 0.76
Cholecystokinin expression in the β-cell leads to increased β-cell area in aged mice and protects from streptozotocin-induced diabetes and apoptosis. Am J Physiol Endocrinol Metab (2015) 0.76
Glucagon-like peptide-1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesity. J Diabetes Investig (2016) 0.75
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 16.62
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature (2003) 16.48
Biology of incretins: GLP-1 and GIP. Gastroenterology (2007) 10.45
The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev (2007) 5.19
Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res (1985) 4.39
A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res (2008) 4.33
The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocr Rev (2008) 3.56
Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med (2002) 3.55
GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab (2006) 3.28
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem (2002) 3.08
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med (1996) 2.94
Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care (2006) 2.46
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A (2002) 2.46
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A (1999) 2.29
Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat Genet (2006) 1.97
Cholecystokinin and gastrin receptors. Physiol Rev (2006) 1.96
Increased islet volume but unchanged islet number in ob/ob mice. Diabetes (2003) 1.95
Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility. Diabetes (2003) 1.61
Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan. Diabetologia (2003) 1.54
Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes (2005) 1.53
Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes (2008) 1.52
Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats. JOP (2004) 1.48
The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest (1999) 1.45
Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia (2005) 1.44
Differential gene expression in well-regulated and dysregulated pancreatic beta-cell (MIN6) sublines. Endocrinology (2003) 1.40
Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology (1997) 1.37
Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab (2009) 1.37
Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes (2003) 1.35
Alpha-Ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice. Am J Physiol Endocrinol Metab (2005) 1.33
Apoptotic signal transduction pathways in diabetes. Biochem Pharmacol (2003) 1.32
Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene (1997) 1.31
The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res (1981) 1.27
Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc Natl Acad Sci U S A (1994) 1.18
Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice. Cell Transplant (2008) 1.16
Pancreatic islets of obese hyperglycemic mice (ob/ob). Pancreas (1992) 1.09
Pancreatic function in CCK-deficient mice: adaptation to dietary protein does not require CCK. Am J Physiol (1999) 1.08
Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function. Am J Physiol Gastrointest Liver Physiol (2006) 1.07
Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth. Clin Cancer Res (2007) 1.04
Contamination with E1A-positive wild-type adenovirus accounts for species-specific stimulation of islet cell proliferation by CCK: a cautionary note. Mol Endocrinol (2010) 1.03
Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide. J Biol Chem (2009) 1.03
Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1). Proc Natl Acad Sci U S A (2006) 1.02
Apoptosis in the pathophysiology of diabetes mellitus. Int J Biochem Cell Biol (2006) 1.01
Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice. Virchows Arch (2001) 0.96
Diet-induced gene expression of isolated pancreatic islets from a polygenic mouse model of the metabolic syndrome. Diabetologia (2009) 0.95
Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes. J Clin Endocrinol Metab (2000) 0.92
Measurement of pancreatic islet cell proliferation by heavy water labeling. Am J Physiol Endocrinol Metab (2007) 0.92
Facile solid-phase synthesis of sulfated tyrosine-containing peptides: total synthesis of human big gastrin-II and cholecystokinin (CCK)-39. J Org Chem (2001) 0.92
Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase. Endocrinology (2006) 0.91
Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas. Gastroenterology (1988) 0.90
Pancreatic CCK(B) receptors: their potential roles in somatostatin release and delta-cell proliferation. Am J Physiol Gastrointest Liver Physiol (2000) 0.89
Ontogeny and species differences in the pancreatic expression and localization of the CCK(A) receptors. Biochem Biophys Res Commun (1999) 0.89
Pathoetiology and prevention of NIDDM lessons from the OLETF rat. J Med Invest (1999) 0.87
The rat pancreatic islets: a reliable tool to study islet responses to cholecystokinin receptor occupation. Regul Pept (2004) 0.87
Hypoglycemia, defective islet glucagon secretion, but normal islet mass in mice with a disruption of the gastrin gene. Gastroenterology (2003) 0.86
Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes (1999) 0.85
Increased beta-cell apoptosis and impaired insulin signaling pathway contributes to the onset of diabetes in OLETF rats. Cell Physiol Biochem (2008) 0.85
The endoproteolytic maturation of progastrin and procholecystokinin. J Mol Med (Berl) (2006) 0.84
Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes (2000) 0.83
Biosynthesis and processing of pro CCK: recent progress and future challenges. Life Sci (2003) 0.82
Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice. Acta Endocrinol (Copenh) (1983) 0.82
Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Biochim Biophys Acta (1991) 0.81
Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. J Clin Endocrinol Metab (1991) 0.81
Devazepide, a nonpeptide antagonist of CCK receptors, induces apoptosis and inhibits Ewing tumor growth. Anticancer Drugs (2009) 0.81
Immunohistochemical analysis of cholecystokinin A receptor distribution in the rat pancreas. Regul Pept (2005) 0.81
Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals. Am J Physiol (1989) 0.80
Evidence for the existence of CCK-producing cells in rat pancreatic islets. Endocrinology (1998) 0.76
The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet (2004) 9.37
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest (2009) 7.09
Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A (2002) 6.00
EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments. Bioinformatics (2013) 4.79
NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J Biol Chem (2004) 4.37
A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res (2008) 4.33
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest (2005) 3.99
Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol (2009) 3.96
Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet (2010) 3.75
Bayesian model selection for genome-wide epistatic quantitative trait loci analysis. Genetics (2005) 3.10
Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet (2008) 2.63
Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet (2008) 2.49
Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab (2011) 2.47
Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development (2011) 2.45
Inferring causal phenotype networks from segregating populations. Genetics (2008) 2.23
BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol (2010) 2.16
The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR. Traffic (2007) 2.09
Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. FASEB J (2008) 2.09
Measurement of protein turnover rates by heavy water labeling of nonessential amino acids. Biochim Biophys Acta (2006) 2.04
Myne-1, a spectrin repeat transmembrane protein of the myocyte inner nuclear membrane, interacts with lamin A/C. J Cell Sci (2002) 2.02
Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J (2008) 1.99
Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat Genet (2006) 1.97
Normal myoblast fusion requires myoferlin. Development (2005) 1.97
Combined expression trait correlations and expression quantitative trait locus mapping. PLoS Genet (2006) 1.93
Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr (2007) 1.91
A model selection approach for the identification of quantitative trait loci in experimental crosses, allowing epistasis. Genetics (2008) 1.91
The transcriptional response of the islet to pregnancy in mice. Mol Endocrinol (2009) 1.89
AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med (2009) 1.88
The genetic landscape of type 2 diabetes in mice. Endocr Rev (2006) 1.88
Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm Genome (2009) 1.87
Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes (2009) 1.82
An efficient Bayesian model selection approach for interacting quantitative trait loci models with many effects. Genetics (2007) 1.82
Bayesian quantitative trait loci mapping for multiple traits. Genetics (2008) 1.80
Development of vocal tract length during early childhood: a magnetic resonance imaging study. J Acoust Soc Am (2005) 1.71
Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates. Am J Physiol Endocrinol Metab (2009) 1.70
Genetic variation in C57BL/6 ES cell lines and genetic instability in the Bruce4 C57BL/6 ES cell line. Mamm Genome (2007) 1.68
Concerning Sichieri R, Cunha DB: Obes Facts 2014;7:221–232. The Assertion that Controlling for Baseline (Pre-Randomization) Covariates in Randomized Controlled Trials Leads to Bias is False. Obes Facts (2015) 1.67
Measurement of cell proliferation by heavy water labeling. Nat Protoc (2007) 1.67
Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals. J Biol Chem (2004) 1.66
Dimension reduction for mapping mRNA abundance as quantitative traits. Genetics (2003) 1.63
CAUSAL GRAPHICAL MODELS IN SYSTEMS GENETICS: A UNIFIED FRAMEWORK FOR JOINT INFERENCE OF CAUSAL NETWORK AND GENETIC ARCHITECTURE FOR CORRELATED PHENOTYPES. Ann Appl Stat (2010) 1.62
Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility. Diabetes (2003) 1.61
Altered control of gastric acid secretion in gastrin-cholecystokinin double mutant mice. Gastroenterology (2004) 1.60
Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Diabetes (2007) 1.59
Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene (2005) 1.59
Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition. J Lipid Res (2004) 1.58
Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex. J Neurosci (2010) 1.58
Impact of nonsense-mediated mRNA decay on the global expression profile of budding yeast. PLoS Genet (2006) 1.55
Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc (2010) 1.51
Phenotypic and transcriptomic changes associated with potato autopolyploidization. Genetics (2007) 1.49
CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy. J Infect Dis (2002) 1.46
Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology (2007) 1.45
Genetic and genomic studies of the BTBR ob/ob mouse model of type 2 diabetes. Am J Ther (2005) 1.45
Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology (2002) 1.43
Mouse atonal homolog 1 directs intestinal progenitors to secretory cell rather than absorptive cell fate. Dev Biol (2010) 1.41
In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia. Blood (2009) 1.40
Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res (2012) 1.39
Bone morphogenetic protein signaling regulates gastric epithelial cell development and proliferation in mice. Gastroenterology (2010) 1.38
Interferon gamma induction of gastric mucous neck cell hypertrophy. Lab Invest (2005) 1.36
Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B. Proc Natl Acad Sci U S A (2002) 1.35
Selective phenotyping for increased efficiency in genetic mapping studies. Genetics (2004) 1.34
Alpha-Ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice. Am J Physiol Endocrinol Metab (2005) 1.33
Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion. Diabetes (2013) 1.33
Intestinal Neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate. Dev Biol (2007) 1.32